Merck Czech Republic made a net profit of CZK 68.6 mil in 2015, up 96.7% when compared to the last year. Total sales reached CZK 1,850 mil, which is up 2.88% when compared to the previous year.
Historically, the company’s net profit reached an all time high of CZK 68.6 mil in 2015 and an all time low of CZK 1.98 mil in 2008.
In terms of sales, Merck Czech Republic reached an all time high of CZK 1,850 mil in 2015 and an all time low of CZK 514 mil in 2003.
Merck Czech Republic's net profit has grown 42.4% a year on average in the last five years while sales have increased by 6.10% a year since 2010.
The firm generated its shareholders an average return on invested capital of 11.5% in the last five years.
As far as Merck Czech Republic's peers are concerned, Roche Czech Republic posted a net profit and sales of CZK 51.0 mil and CZK 5,445 mil in 2015, Bayer Czech Republic generated a net profit of CZK 123 mil (with sales of CZK 4,277 mil) and Amgen Czech Republic netted CZK 35.8 mil (sales of CZK 604 mil).